Title
Revised Guidelines on Yellow Prescription Pads
Law
Doh Administrative Order No. 2012- 0002
Decision Date
Feb 6, 2012
The Philippine Jurisprudence case provides revised guidelines on the distribution and sale of yellow prescription pads, ensuring accountability, transparency, and availability for authorized health personnel in the management and usage of these pads containing dangerous drugs and/or controlled precursors and essential chemicals.

Law Summary

Objective

  • To enhance availability of yellow prescription pads to authorized health professionals.
  • To improve usage control and monitoring mechanisms for these pads.

Scope

  • Applies nationwide covering all DOH Centers for Health Development, DOH hospitals, and partner agencies such as the Dangerous Drugs Board (DDB).

General Guidelines

DOH Central Office Responsibilities

  • The Special Concerns Technical Cluster (SCTC) through the Dangerous Drug Abuse Prevention and Treatment Program forecasts pad requirements, plans funding, and coordinates printing.
  • Materials Management Division handles storage and delivery.
  • The program provides updates on shipments to distribution sites.
  • Maintains safekeeping of records via the IT database developed by the Information Management Service.
  • Collaborates with partner agencies to ensure effective distribution, use, and security.

DOH-CHDs, Hospitals, and Partner Agencies

  • FDA Regulatory Officers at CHDs and designated hospital personnel manage sales and distribution.
  • Use of a web-based IT database is mandatory for record-keeping, including detailed user information: name, license number, addresses, and telephone numbers.
  • Maintain confidentiality and security of records.
  • Only licensed S2 professionals (issued by PDEA) may purchase pads.
  • Limit of 10 prescription pad booklets per licensee at a time.
  • Serial numbers of sold booklets must be recorded within two weeks.
  • Used pads must be surrendered and kept for monitoring by PDEA for at least two years.
  • Purchasers can only acquire pads equivalent to the number returned/validated.
  • Release of pads requires presentation of payment receipt.
  • First-time purchasers receive orientation on:
    • Carbonized paper use without carbon sheets.
    • Legal penalties for unnecessary prescription of dangerous drugs (12-20 years imprisonment, fines of P100,000 to P500,000).
    • Legal penalties for unlawful prescription (life imprisonment to death, fines of P500,000 to P10,000,000).
  • Stock monitored; notification required when only 10% stock remains.

Price and Payment

  • Pads sold at PHP 250 per booklet.
  • Payments accepted at CHD/Hospital Cashiers and DDB Cashier Offices.
  • Hospitals retain proceeds for use under existing financial rules.
  • CHDs and DDB sales are subject to standard auditing and accounting regulations.

Additional Procedures

  • Purchasers must present valid PRC License ID and PDEA-issued S2 License.
  • Representatives authorized only for second and subsequent purchases with proper documentation and validation.
  • Replacement pads for lost booklets require:
    • Written report within two weeks.
    • Affidavit of loss.
    • Police report (blotter) original or duplicate.

Repealing Clause

  • Previous inconsistent or contrary issuances repealed or modified accordingly.

Separability Clause

  • If any provision is held invalid or unenforceable, other provisions remain effective.

Effectivity

  • The guidelines take effect immediately upon adoption on 06 February 2012.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster—building context before diving into full texts.